scholarly article | Q13442814 |
P50 | author | Tony Wyss-Coray | Q23782672 |
Michael Platten | Q38799497 | ||
Jian Luo | Q43291036 | ||
P2093 | author name string | Hui Zhang | |
Lawrence Steinman | |||
Peggy P Ho | |||
Tobias V Lanz | |||
Robert Axtell | |||
Hrishikesh Srinagesh | |||
Zhaoqing Ding | |||
Ankur N Agrawal | |||
P2860 | cites work | Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice | Q37468752 |
Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma | Q40835307 | ||
Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease | Q43076168 | ||
The brain renin-angiotensin system in transgenic mice carrying a highly regulated human renin transgene | Q43851353 | ||
Control of dendritic cell differentiation by angiotensin II. | Q44270057 | ||
Angiotensin II type 1 receptor interaction is an important regulator for the development of pancreatic fibrosis in mice | Q44796893 | ||
The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis | Q45048879 | ||
The renin-angiotensin system and the developing retinal vasculature | Q45280910 | ||
Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts | Q46052970 | ||
Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan | Q46167652 | ||
Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice | Q46525969 | ||
Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions | Q46822097 | ||
Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. | Q46986151 | ||
Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1. | Q47999476 | ||
Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1 | Q48655440 | ||
Global analysis of Smad2/3-dependent TGF-beta signaling in living mice reveals prominent tissue-specific responses to injury | Q48840754 | ||
Participation of thrombospondin-1 in the activation of latent transforming growth factor-beta in malignant glioma cells | Q48853907 | ||
Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. | Q52519170 | ||
Evidence that macrophages in atherosclerotic lesions contain angiotensin II | Q77198552 | ||
Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart | Q77299992 | ||
The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta | Q77388281 | ||
TGF-beta 1 production in radiation nephropathy: role of angiotensin II | Q77759932 | ||
Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines | Q81072711 | ||
Role of transforming growth factor beta in human disease | Q28143408 | ||
Regulation of immune responses by TGF-beta | Q28271433 | ||
TGF-beta: a master of all T cell trades | Q28290413 | ||
Thrombospondin-1 is a major activator of TGF-beta1 in vivo | Q28513856 | ||
Characterisation of a thymic renin-angiotensin system in the transgenic m(Ren-2)27 rat | Q28575221 | ||
Highly sensitive and specific bioassay for measuring bioactive TGF-beta | Q33237082 | ||
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. | Q33319975 | ||
Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection | Q33843007 | ||
Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta | Q33902166 | ||
Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells | Q34150690 | ||
Regulation of blood pressure by the type 1A angiotensin II receptor gene | Q34451124 | ||
Recent progress towards a molecular understanding of Marfan syndrome | Q34465738 | ||
The logic of TGFbeta signaling. | Q34522372 | ||
Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states | Q35110459 | ||
Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration | Q35722374 | ||
Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals | Q35820693 | ||
Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. | Q36088936 | ||
Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta | Q36361126 | ||
Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. | Q36370963 | ||
T(H)-17 cells in the circle of immunity and autoimmunity | Q36765453 | ||
Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literature | Q37058920 | ||
Regulation of T-cell function by endogenously produced angiotensin II. | Q37100479 | ||
Update on tissue renin-angiotensin systems | Q37139367 | ||
Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice | Q37147228 | ||
Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis | Q37327995 | ||
Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system | Q37329566 | ||
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. | Q37329670 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
encephalitis | Q199615 | ||
P304 | page(s) | 2782-2794 | |
P577 | publication date | 2010-07-12 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Angiotensin II sustains brain inflammation in mice via TGF-beta | |
P478 | volume | 120 |
Q48011877 | 6-Hydroxydopamine induces brain vascular endothelial inflammation |
Q24306614 | A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme |
Q41701311 | A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information. |
Q37202385 | AAV8-Mediated Angiotensin-Converting Enzyme 2 Gene Delivery Prevents Experimental Autoimmune Uveitis by Regulating MAPK, NF-κB and STAT3 Pathways |
Q36098738 | AGTR1 gene variation: association with depression and frontotemporal morphology |
Q35173719 | AT1 receptor antagonism does not influence early radiation-induced changes in microglial activation or neurogenesis in the normal rat brain |
Q36148314 | Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders |
Q42697695 | Acute hypertensive response in patients with intracerebral hemorrhage pathophysiology and treatment |
Q103034460 | Altered astrocytic function in experimental neuroinflammation and multiple sclerosis |
Q35827935 | Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders |
Q36410269 | Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders |
Q43239444 | Angiotensin II drives the production of tumor-promoting macrophages |
Q48546748 | Angiotensin II type 1 receptor expression in astrocytes is upregulated leading to increased mortality in mice with myocardial infarction-induced heart failure |
Q87935400 | Angiotensin IV is induced in experimental autoimmune encephalomyelitis but fails to influence the disease |
Q52342055 | Angiotensin-converting enzyme in innate and adaptive immunity. |
Q58085056 | Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma |
Q53653853 | Anti-inflammatory effects of fimasartan via Akt, ERK, and NFκB pathways on astrocytes stimulated by hemolysate. |
Q88956304 | Astrocytes and the Renin Angiotensin System: Relevance in Disease Pathogenesis |
Q33769818 | Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice |
Q22306336 | Autonomic-Immune-Vascular Interaction: An Emerging Concept for Neurogenic Hypertension |
Q34390088 | Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications |
Q38100285 | Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system |
Q92097275 | Brain angiotensin type-1 and type-2 receptors: cellular locations under normal and hypertensive conditions |
Q47842158 | Candesartan ameliorates brain inflammation associated with Alzheimer's disease. |
Q30528431 | Candesartan, an angiotensin II AT₁-receptor blocker and PPAR-γ agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice. |
Q38461657 | Cerebroprotective effects of RAS inhibitors: Beyond their cardio-renal actions. |
Q37620176 | Cerebrospinal fluid protein carbonylation identifies oxidative damage in autoimmune demyelination |
Q42700774 | Chronic high dose of captopril induces depressive-like behaviors in mice: possible mechanism of regulatory T cell in depression |
Q104486531 | Chronically infused angiotensin II induces depressive-like behavior via microglia activation |
Q38781945 | Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension. |
Q50194649 | Coagulation factors and multiple sclerosis : Key factors in the pathogenesis? |
Q35195660 | Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats |
Q36699626 | Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus |
Q38116974 | Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease |
Q38207555 | Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal |
Q58794337 | Differential effects of angiotensin II type I receptor blockers on reducing intraocular pressure and TGFβ signaling in the mouse retina |
Q48643095 | Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice |
Q34323132 | Direct pro-inflammatory effects of prorenin on microglia |
Q50104275 | Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma? |
Q26783348 | Dopamine Receptors and Neurodegeneration |
Q99711187 | Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis |
Q93115512 | ECMO attenuates inflammation response and increases ATPase activity in brain of swine model with cardiac arrest compared with CCPR |
Q38021079 | Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases |
Q49016420 | Effect of dietary β carotene on cerebral aneurysm and subarachnoid haemorrhage in the brain apo E-/- mice. |
Q55516350 | Effects of Systolic Blood Pressure on Brain Integrity in Multiple Sclerosis. |
Q38603674 | Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice |
Q38781028 | Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease |
Q35878979 | Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific |
Q41847076 | Excessive leukotriene B4 in nucleus tractus solitarii is prohypertensive in spontaneously hypertensive rats |
Q46336800 | Expression of angiotensin II and its receptors in activated microglia in experimentally induced cerebral ischemia in the adult rats |
Q36632049 | Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra |
Q36270869 | Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells. |
Q35949121 | Frataxin Deficiency Promotes Excess Microglial DNA Damage and Inflammation that Is Rescued by PJ34 |
Q34620012 | Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor β1 in mice. |
Q39485775 | Heterologous regulation of the cannabinoid type 1 receptor by angiotensin II in astrocytes of spontaneously hypertensive rats |
Q54241919 | High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the Renin Angiotensin system. |
Q39115238 | Immunologic Effects of the Renin-Angiotensin System |
Q35819219 | Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease. |
Q37921158 | LOX-1 and angiotensin receptors, and their interplay |
Q43833906 | LPS antagonism of TGF-β signaling results in prolonged survival and activation of rat primary microglia |
Q48267087 | Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death |
Q33831494 | Losartan prevents acquired epilepsy via TGF-β signaling suppression |
Q38965333 | Macrophages in neuroinflammation: role of the renin-angiotensin-system. |
Q38969930 | Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration. |
Q51070174 | Modulation of the kallikrein/kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis. |
Q38264237 | Neuroprotective effects of angiotensin receptor blockers. |
Q48103115 | Neuroprotective mechanism of losartan and its interaction with nimesulide against chronic fatigue stress |
Q26998948 | Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke |
Q37809435 | New insights into angiotensin receptor actions: from blood pressure to aging |
Q35836666 | Nontraditional roles of angiotensin-converting enzyme |
Q48414468 | Obesity-associated extracellular mtDNA activates central TGFβ pathway to cause blood pressure increase |
Q30412966 | Pro-cognitive properties of T cells |
Q37157311 | Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis |
Q54356901 | Regulation of angiotensinogen by angiotensin II in mouse primary astrocyte cultures. |
Q49947511 | Renin angiotensin system and its role in biomarkers and treatment in gliomas |
Q42098043 | Renin-Angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction |
Q27009109 | Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract |
Q38260925 | Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease |
Q57823452 | Role of Thrombospondin-1 in Mechanotransduction and Development of Thoracic Aortic Aneurysm in Mouse and Humans |
Q28081615 | Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control |
Q43554936 | Role of thrombospondin-1 in the development of kidney diseases |
Q36487749 | Roles of Brain Angiotensin II in Cognitive Function and Dementia |
Q24297472 | Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L |
Q37468713 | Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-β. |
Q33967281 | TGF-β signaling initiated in dendritic cells instructs suppressive effects on Th17 differentiation at the site of neuroinflammation |
Q33771600 | TGFβ produced by IL-10 redirected astrocytes attenuates microglial activation |
Q37316413 | TGFβ regulates persistent neuroinflammation by controlling Th1 polarization and ROS production via monocyte-derived dendritic cells |
Q55007046 | Targeting Renin-Angiotensin System Against Alzheimer's Disease. |
Q36462348 | Targeting the TGFβ signalling pathway in disease |
Q36019970 | Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies |
Q36136825 | Telmisartan directly ameliorates the neuronal inflammatory response to IL-1β partly through the JNK/c-Jun and NADPH oxidase pathways |
Q92069261 | The Effect of Candesartan Alone and Its Combination With Estrogen on Post-traumatic Brain Injury Outcomes in Female Rats |
Q92213495 | The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis |
Q36632900 | The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesis |
Q37857982 | The immunopathophysiology of multiple sclerosis |
Q38187467 | The microfibril hypothesis of glaucoma: implications for treatment of elevated intraocular pressure |
Q39250678 | Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction. |
Q47243282 | Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease |
Q26823508 | Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms |
Q50104779 | Transforming growth factor-β in stem cells and tissue homeostasis |
Q27468826 | Type-1 angiotensin receptor signaling in central nervous system myeloid cells is pathogenic during fatal alphavirus encephalitis in mice |
Q36630037 | Wnt/β-catenin signaling and renin-angiotensin system in chronic kidney disease |
Search more.